Christopher Gaffney's research while affiliated with Memorial Sloan Kettering Cancer Center and other places

Publications (38)

Article
Background: There is limited ability to accurately diagnose and clinically stage patients with upper tract urothelial carcinoma (UTUC). The most easily available and widely used urinary biomarker is urine cytology, which evaluates cellular material yet lacks sensitivity. We sought to assess the feasibility of performing next-generation sequencing...
Article
TPS4614 Background: Alterations to FGFR3 are the most common somatic mutations in non-muscle invasive bladder cancer (NMIBC), present in 40-60% of high-grade Ta and > 80% of recurrent low grade Ta tumors. FGFR3 mutations are also known to be associated with a “cold” tumor microenvironment (TME) that may mediate BCG resistance. Erdafitinib, a target...
Article
e17092 Background: Prostate biopsy is among the most common oncologic procedures performed annually. A substantial proportion of patients experience significant morbidity related to biopsy, including pain, anxiety, and discomfort which may discourage follow-up biopsy crucial for identifying progression or discourage enrollment in active surveillanc...
Article
Objectives: To investigate the utilization of holmium laser enucleation of the prostate (HoLEP) using a large real-world cohort. We compare the safety, readmission, and retreatment rates of HoLEP to other widely used endoscopic surgical interventions for benign prostatic hyperplasia (BPH) including transurethral resection of the prostate (TURP), p...
Article
571 Background: There are abundant potential permutations of novel or combination therapeutics that could be tested in non-muscle invasive bladder cancer (NMIBC), but the ability to study these therapies is limited. Window of opportunity trials (WOOT) may accelerate otherwise costly and slow drug evaluation by testing response to treatment during t...
Article
TPS579 Background: The standard of care for high-risk non-muscle invasive bladder cancer (NMIBC) after exposure to induction only BCG or relapse >12 months after “adequate” BCG is retreatment with BCG. However, ~50% of patients will relapse within 6 months. Thus, there is a critical need to develop novel combination therapies to improve BCG immunot...
Article
Full-text available
PurposeTo assess the impact of microsurgical varicocelectomy technique on clinical outcomes.Methods Men diagnosed with varicocele between 2017 and 2020 were reviewed. We included men who underwent microsurgical varicocelectomy by two high-volume surgeons who differed in surgical technique: Method (1) testicular delivery with gubernacular vein ligat...
Article
We aimed to characterise diverse practice patterns for vasal reconstruction and to determine whether surgeon volume is associated with vasoepididymostomy performance at the time of reconstruction. We identified adult men who underwent vasal reconstruction from 2000 to 2020 in Premier Healthcare Database and determined patient, surgeon, cost and hos...
Article
Purpose To review and compare outcomes of prostatic artery embolization (PAE) with three other minimally-invasive surgical treatments for benign prostatic hyperplasia (BPH), including photo selective vaporization (PVP), prostatic urethral lift (PUL), and water vapor thermal therapy (WV) for the treatment of benign prostatic hyperplasia (BPH). Mate...
Article
Purpose Unlike many other cancers, measurement of primary prostate tumor size has no defined role in the management of localized prostate cancer. Here, we assess whether prostate tumor size is associated with aggressive tumor biology using biomarkers of genomic risk. Materials and methods We abstracted or imputed tumor size from the primary pathol...
Article
Background: Adoption of prostate magnetic resonance imaging (MRI) before biopsy is based on evidence demonstrating superior detection of clinically significant prostate cancer on biopsy. Whether this is due to the detection of otherwise occult higher grade cancers or preferential sampling of higher grade areas within an otherwise low-grade cancer...
Article
Background Speckle-type POZ protein (SPOP) mutation defines one of the dominant prostate cancer genomic subtypes, yet the impact of this mutation on clinical prognosis is unknown. Methods We defined SPOP mutation status either by DNA sequencing or by transcriptional signature in a pooled retrospective multi-institutional cohort, the Decipher retro...
Article
Objectives: To characterize trends in the incidence and severity of post-biopsy infection using nationally representative data, given that population-based data have revealed an increasing incidence of post-prostate biopsy infections through 2007. Little is known about contemporary trends in prostate biopsy related infections and associated risk-f...
Article
Purpose: We retrospectively investigated the genomic prostate score assay in clinical practice at an urban tertiary care academic center. Materials and methods: We reviewed all Genomic Prostate Score results acquired during a 3-year period. Changes in patient NCCN (National Comprehensive Cancer Network®) risk group, including very low, low, inte...

Citations

... In addition, the limited amount of eligible studies reduced the credibility of the final conclusions. Another nine articles [12,[14][15][16][17][18][19][20][21] were added to this research compared to the latest meta-analysis [13], which made the outcomes more convincing and credible. Gald conducted an additional stratified analysis utilizing the semen concentration of the patients [20]. ...
... More recently, improvements in endourologic instrumentation have permitted minimally invasive approaches to ejaculatory duct pathology, such as seminal vesiculoscopy or balloon dilation of the ejaculatory ducts [35,36]. Unusual pathology may be encountered, such as symptomatic stones requiring laser lithotripsy or basketing, blood clots requiring irrigation, or tumors necessitating biopsy [37,38]. ...
... New modalities and approaches have expanded the indications for the surgical treatment of BPH [6,7]. For example, GreenLight photovaporization of the prostate (PVP) has been shown to reduce the risk of intraoperative bleeding and postoperative hematuria in patients requiring anticoagulant and/or antiplatelet therapy, and has been associated with lower rates of major acute cardiac events [8][9][10]. ...
... If the tumor sizes > 8 mm in the biopsies, the likelihood is 90% to be upgraded from GS6 to GS7 in the prostatectomy specimens [32]. Molecular studies show that tumor size is an independent factor in the accumulation of genomic risk factors [33]. Furthermore, molecular studies have shown that even small foci can metastasize [34]. ...
... Prostate cancer (PCa) is the most common malignancy in men (1). As for androgen-dependent cancer, androgen-receptor signaling plays a crucial role in PCa development and progression (2). ...
... A recent national survey of urologists and radiation oncologists showed that while both specialties reported positive attitudes towards mpMRI, only about a quarter of providers in both groups actually ordered mpMRI [1]. Likewise, a recent review of SEER data showed that while more people are using mpMRI in men with prior biopsy and no prior biopsy, there remains significant heterogeneity in utilization patterns, with increased utilization reported in patients with higher socioeconomic status [2]. e findings suggest that one of the main factors limiting the accessibility of mpMRI is its affordability [3]. ...
... The outcomes of interest to determine the intensity of AS were PSA testing, prostate surveillance biopsies, and magnetic resonance imagining (MRI) scans. The HCPCS/CPT codes used were similar to those in previous studies [6,16,17]. PSA testing, surveillance biopsies, and MRI scans performed were counted only if they were performed 1 month after cancer diagnosis date (diagnosis date was estimated as the first day of the month of diagnosis). ...
... Finally, results from a 2020 study including 5,811 patients with prostate cancer from retrospective multi-institutional cohorts showed that SPOP mutations were associated with a decreased rate of adverse pathology at radical prostatectomy (OR 0.57, 95% CI = 0.34−0.93, P = 0.026), independently of preoperative PSA, age, and pathological Gleason score; however, SPOP mutations were not associated with biochemical recurrence, metastasis-free survival, or cancer-specific survival, independently of pathological information, indicating that SPOP mutations are independently Nature reviews | Urology P e r s P e c t i v e s 0123456789();: associated with favourable pathology at prostatectomy 66 . The paradoxical effect of SPOP mutations on genomic instability in prostate cancer despite a correlation with improved clinical outcomes has not yet been explained; some hypotheses, which remain to be proven, are the increased susceptibility of tumours harbouring SPOP mutations to anti-androgen therapies, or the mutual exclusivity of this mutation with other alterations that confer aggressive phenotypes, such as ETS family gene mutations. ...
... The interplay between infection and AUR remains unclear, but based Approximately 21% of the infection cohort also went into AUR, but due to the low number of overall infection events, it is difficult to make definite claims here. Overall, we feel the most compelling finding we identified was older age, and while not well studied, it has been established as a risk factor for infection after TR and TP biopsy [24]. Contrary to studies like Shoag et al., we could not confirm age as an independent risk factor for infection in our regression model [24]. ...
... Pierce et al. (24) realizaron una prueba de Cetirizina a un varón de 28 años con la indicación de que tuviera un orgasmo semanalmente. Tras 4 semanas, el paciente informó de una mejora significativa de los calambres abdominales y de sus deposiciones. ...